📰 Alexander Kulla News
Alexander Kulla News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alexander Kulla. Real-time updates on events, politics, business and more.
October 10, 2023
Merck a leading science and technology company today announced the presentation of new analyses from the MAVENCLAD cladribine tablets MAGNIFYMS study which demonstrated that patients with relapsing multiple sclerosis RMS experienced sustained reduction in serum neurofilament light chain NfL indicating that MAVENCLAD reduced neuronal injury over two years.
October 10, 2023
ROCKLAND, Mass., October 10, 2023--EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of new analyses from the MAVENCLAD® (cladribine) tablets MAGNIFY-MS study, which demonstrated that patients with relapsing multiple sclerosis (RMS) experienced sustained reduction in serum neurofilament light chain (NfL), indicating that MAVENCLAD reduced neuronal injury over two years. Additional data include two real-worl...